UBS Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Buy |
881,481
+214,317
| +32% | +$6.28M | ﹤0.01% | 1659 |
|
|
2025
Q1 | $17.2M | Buy |
667,164
+581,236
| +676% | +$14.9M | ﹤0.01% | 1923 |
|
|
2024
Q4 | $2.48M | Buy |
85,928
+79,783
| +1,298% | +$2.3M | ﹤0.01% | 3554 |
|
|
2024
Q3 | $146K | Buy |
6,145
+2,083
| +51% | +$49.5K | ﹤0.01% | 4911 |
|
|
2024
Q2 | $70.2K | Sell |
4,062
-209
| -5% | -$3.61K | ﹤0.01% | 5285 |
|
|
2024
Q1 | $95.4K | Sell |
4,271
-116
| -3% | -$2.59K | ﹤0.01% | 5090 |
|
|
2023
Q4 | $80.5K | Buy |
4,387
+2,151
| +96% | +$39.5K | ﹤0.01% | 5101 |
|
|
2023
Q3 | $38.8K | Sell |
2,236
-614
| -22% | -$10.7K | ﹤0.01% | 5324 |
|
|
2023
Q2 | $51.9K | Buy |
2,850
+1,569
| +122% | +$28.6K | ﹤0.01% | 5395 |
|
|
2023
Q1 | $22K | Buy |
1,281
+1,063
| +488% | +$18.2K | ﹤0.01% | 5924 |
|
|
2022
Q4 | $5.07K | Hold |
218
| – | – | ﹤0.01% | 8029 |
|
|
2022
Q3 | $5K | Sell |
218
-6,671
| -97% | -$153K | ﹤0.01% | 8137 |
|
|
2022
Q2 | $132K | Buy |
6,889
+6,133
| +811% | +$118K | ﹤0.01% | 4233 |
|
|
2022
Q1 | $27K | Sell |
756
-370
| -33% | -$13.2K | ﹤0.01% | 6077 |
|
|
2021
Q4 | $98K | Buy |
1,126
+768
| +215% | +$66.8K | ﹤0.01% | 5261 |
|
|
2021
Q3 | $41K | Buy |
+358
| New | +$41K | ﹤0.01% | 5396 |
|